Grifols and Saudi Sovereign Fund Plan to Partner on Blood Plasma Medicines
Posted on 02/18/2020
Spanish pharmaceutical company Grifols, S.A signed a non-binding agreement with Saudi Arabia’s Public Investment Fund (PIF). The agreement entails Grifols helping Saudi Arabia to produce blood plasma-derived medicines through a joint venture. The JV will develop plasma collection centers and production facilities, including a fractionation and a purification facility in Saudi Arabia. The financing needs […]
